OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.

The company is positioning this approach as a turning point for robotics, comparable to what large generative models have done for text and images.

If your AI is stuck in demos, the problem isn’t the model — it’s that you don’t have forward-deployed engineers.

The free download is not a trial or evaluation version. It includes the SDA runtime, Studio, and API with no time limits, capacity restrictions, or disabled capabilities. Software-defined automation ...

Our columnist explores the new 'AI continuum' from a developer's perspective, dispels some misconceptions, addresses the skills gap, and offers some practical strategies for marshaling the power of ...